# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-001850
Filing Date
2023-01-06
Accepted
2023-01-06 16:05:17
Documents
40
Period of Report
2023-01-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm232502d1_8k.htm iXBRL | 8-K | 27891
2 | EXHIBIT 99.1 | tm232502d1_ex99-1.htm | EX-99.1 | 39319
6 | GRAPHIC | tm232502d1_ex99-1img001.jpg | GRAPHIC | 110099
7 | GRAPHIC | tm232502d1_ex99-1img002.jpg | GRAPHIC | 216481
8 | GRAPHIC | tm232502d1_ex99-1img003.jpg | GRAPHIC | 204052
9 | GRAPHIC | tm232502d1_ex99-1img004.jpg | GRAPHIC | 160315
10 | GRAPHIC | tm232502d1_ex99-1img005.jpg | GRAPHIC | 101209
11 | GRAPHIC | tm232502d1_ex99-1img006.jpg | GRAPHIC | 147504
12 | GRAPHIC | tm232502d1_ex99-1img007.jpg | GRAPHIC | 179821
13 | GRAPHIC | tm232502d1_ex99-1img008.jpg | GRAPHIC | 124097
14 | GRAPHIC | tm232502d1_ex99-1img009.jpg | GRAPHIC | 150620
15 | GRAPHIC | tm232502d1_ex99-1img010.jpg | GRAPHIC | 175502
16 | GRAPHIC | tm232502d1_ex99-1img011.jpg | GRAPHIC | 141628
17 | GRAPHIC | tm232502d1_ex99-1img012.jpg | GRAPHIC | 137215
18 | GRAPHIC | tm232502d1_ex99-1img013.jpg | GRAPHIC | 140647
19 | GRAPHIC | tm232502d1_ex99-1img014.jpg | GRAPHIC | 132411
20 | GRAPHIC | tm232502d1_ex99-1img015.jpg | GRAPHIC | 114345
21 | GRAPHIC | tm232502d1_ex99-1img016.jpg | GRAPHIC | 132146
22 | GRAPHIC | tm232502d1_ex99-1img017.jpg | GRAPHIC | 114784
23 | GRAPHIC | tm232502d1_ex99-1img018.jpg | GRAPHIC | 117787
24 | GRAPHIC | tm232502d1_ex99-1img019.jpg | GRAPHIC | 148767
25 | GRAPHIC | tm232502d1_ex99-1img020.jpg | GRAPHIC | 140403
26 | GRAPHIC | tm232502d1_ex99-1img021.jpg | GRAPHIC | 241929
27 | GRAPHIC | tm232502d1_ex99-1img022.jpg | GRAPHIC | 178391
28 | GRAPHIC | tm232502d1_ex99-1img023.jpg | GRAPHIC | 176459
29 | GRAPHIC | tm232502d1_ex99-1img024.jpg | GRAPHIC | 153146
30 | GRAPHIC | tm232502d1_ex99-1img025.jpg | GRAPHIC | 73653
31 | GRAPHIC | tm232502d1_ex99-1img026.jpg | GRAPHIC | 153177
32 | GRAPHIC | tm232502d1_ex99-1img027.jpg | GRAPHIC | 92255
| Complete submission text file | 0001104659-23-001850.txt |  | 5709596

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA | anvs-20230106.xsd | EX-101.SCH | 3039
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | anvs-20230106_lab.xml | EX-101.LAB | 34476
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | anvs-20230106_pre.xml | EX-101.PRE | 22599
34 | EXTRACTED XBRL INSTANCE DOCUMENT | tm232502d1_8k_htm.xml | XML | 3707

Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-3913
Annovis Bio, Inc. (Filer) CIK: 0001477845 (see all company filings)

EIN.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39202 | Film No.: 23515085
SIC: 2834 Pharmaceutical Preparations